Engert A, Schultz H, Elter T. Minimal residual disease following chemoimmunotherapy for patients with relapsed chronic lymphocytic leukemia. Hematol Meeting Rep [Internet]. 2009 May 28 [cited 2024 Nov. 26];1(2). Available from: https://www.pagepress.org/journals/hmr/article/view/228